# Document content update

## You (2025-12-03T18:41:42.062814+00:00)

{"content_type": "user_editable_context", "user_profile": "Very important: The user's timezone is Asia/Kolkata. The current date is 04th December, 2025. Any dates before this are in the past, and any dates after this are in the future. When dealing with modern entities/companies/people, and the user asks for the 'latest', 'most recent', 'today's', etc. don't assume your knowledge is up to date; you MUST carefully confirm what the *true* 'latest' is first. If the user seems confused or mistaken about a certain date or dates, you MUST include specific, concrete dates in your response to clarify things. This is especially important when the user is referencing relative dates like 'today', 'tomorrow', 'yesterday', etc -- if the user seems mistaken in these cases, you should make sure to use absolute/exact dates like 'January 1, 2010' in your response.\nThe user's location is Hyderabad, Telangana, India.\n\n", "user_instructions": "If I ask about events that occur after the knowledge cutoff or about a current/ongoing topic, do not rely on your stored knowledge. Instead, use the search tool first to find recent or current information. Return and cite relevant results from that search before answering the question. If you’re unable to find recent data after searching, state that clearly.\n DO NOT PUT LONG SENTENCES IN MARKDOWN TABLES. Tables are for keywords, phrases, numbers, and images. Keep prose in the body."}

## You (2025-12-03T18:41:42.063021+00:00)

{"content_type": "user_editable_context", "user_profile": "", "user_instructions": "\nCurrently there are no APIs available through API Tool. Refrain from using API Tool until APIs are enabled by the user."}

## You (2025-12-03T18:41:39.282000+00:00)

add the following content in the document opened in this tab. Use appropriate styling rules. 

# Account Health – Scope Confirmation & Next Steps

Thanks — now that we have the latest designs, the meeting transcript, and alignment on the core vision, this document summarizes how we (design) are understanding the scope **and** how we propose to move forward.

This is written to:

* Show that we clearly understand the problem space and future direction.
* Call out where we see complexity or risk (roll‑ups, subjective health, lifecycle status, IA).
* Propose concrete next steps so we can move from concept to executable design work.

It deliberately **does not restate** all of the existing UI or metrics; everyone here already knows the current system well. Instead, it focuses on the *delta* we need to design for.

---

## 1. What we heard and how we’re framing the problem

From the recent conversations, we’re treating “Account Health” as evolving from a **single‑account cockpit** into a **multi‑layered health system** that must support:

1. **Apex accounts** with subsidiaries, where health exists at:

   * Individual account level ("Alphabet as a customer").
   * Apex roll‑up level ("Alphabet as a parent of Google, YouTube, Boston Dynamics, etc.").

2. **Two parallel views of health**:

   * **Objective health** – system‑calculated scores derived from existing KPIs (deployment, technical, adoption, support).
   * **Subjective health** – field / account‑team judgment that layers additional context on top of system data.

3. **Explainability and root cause clarity**, without forcing users to hunt through multiple tabs to understand why a product or account is red.

4. **Clear product lifecycle status** (Active, Inactive, Will‑Churn, Churned) that shapes how health is interpreted and how QBR / renewal conversations happen.

Our goal as design is to make this system **legible, navigable, and trustworthy** for the people who use it in high‑stakes conversations (CSMs, AEs, execs), while keeping the implementation viable for data and engineering.

---

## 2. Where we see complexity / potential issues

Below are the key areas where we see design and system complexity. These are also the areas where further alignment and documentation will reduce risk and rework later.

### 2.1 Roll‑ups (Apex ↔ subsidiary ↔ product)

**What’s straightforward:**

* We can roll up *counts* and *rates* (e.g., case counts, MTTR, adoption %, license volumes) as long as we agree on the aggregation rules.
* We can roll up health states using a simple hierarchy (Critical > At‑Risk > Healthy).

**Where we see potential issues:**

1. **"Two truths" at the Apex level.**

   * Example: Alphabet as a standalone account is Healthy; Alphabet as a roll‑up is Critical because Boston Dynamics is red.
   * We need a clear pattern to show **both** without confusing users.

2. **Not everything can be meaningfully rolled up.**

   * Detailed artifacts like case lists, pit‑stop timelines, PS project tables, and configuration details lose meaning when merged.
   * For these, roll‑up should be: **aggregated signal + drill‑down**, not a single mega‑timeline or mega‑table.

3. **Health semantics across different products.**

   * Health drivers for Prisma Access vs CDSS vs PA‑Series are structurally different.
   * We should ensure the roll‑up doesn’t imply false equivalence (e.g., a single “Critical” that hides whether it’s deployment‑driven or technical‑driven).

4. **IA and mental model at Apex.**

   * Today, all screens assume “one account.”
   * At Apex, users need to understand: *Which subsidiaries are pulling us down? Which products at which subsidiaries? How do I drill into that quickly?*

**Design implications:**

* Apex view must explicitly distinguish:

  * **Apex‑as‑account health** (direct purchases/install base).
  * **Apex roll‑up health** (aggregated subsidiary impact).
* We’ll prefer a **summary + hotspot list** pattern: e.g., “Top 3 subsidiaries dragging health down,” each with direct links into the existing single‑account lenses.
* For metrics that don’t roll up well, we will **not** force aggregation and will instead provide guided paths to the right child views.

---

### 2.2 Subjective health (human judgment on top of system scores)

We haven’t yet established subjective overrides as a full workflow, but the need is clear:

* Field teams want to express, “The system shows Critical, but we’ve mitigated the underlying issue and are confident,” or the opposite.

**Key complexities we see:**

1. **Scope of overrides.**

   * We believe overrides should apply only to **health states**, not raw metrics.
   * Candidate fields:

     * Overall account health
     * Technical health
     * Deployment & adoption health
     * Apex roll‑up health (for leadership‑level judgment)
     * (Optional) per‑product health where necessary

2. **Governance and roles.**

   * Who is allowed to set subjective health? CSM, AE, renewal rep, SE?
   * Does it require approval or is it a free‑form note?

3. **Lifetime and freshness.**

   * An override from six months ago is dangerous if it outlives the underlying data.
   * We’ll need rules like: *expires after X days* or *must be renewed when system health changes state*.

4. **Conflict representation.**

   * System says Critical, field says Healthy.
   * We need a clear, non‑ambiguous visual pattern that shows **both** and invites the user to understand why.

**Design implications:**

* We should treat subjective health as a **layer of annotation** with metadata (who, when, why), not a replacement field.
* The UI will show dual badges, e.g., “System: Critical / Field: At‑Risk,” with a quick way to see the justification.
* In the first iteration, we’d recommend keeping overrides limited to **overall account and Apex roll‑up** to reduce complexity.

---

### 2.3 Product & lifecycle status (Active / Inactive / Will‑Churn / Churned)

Right now, the designs surface a lot of lifecycle signals (support active/inactive, license terms, etc.), but the **state vocabulary isn’t unified**. That creates risk of:

* Misaligned mental models between CS, Renewals, and Product.
* Health scores on products that are effectively “dead” or “not yet started.”

**Where we see issues:**

1. **Fragmented labels.**

   * “Inactive support,” “never had support,” expired licenses, etc., all communicate lifecycle in different ways.

2. **Health on products that shouldn’t be evaluated.**

   * A churned product shouldn’t show “Critical” health in the same way as an active one; that confuses QBR messaging.

3. **Renewal workflows.**

   * The “Will‑Churn” window (contract ended, tenant still active, renewal in play) is key for CS and Renewals, but today it’s not clearly visualized.

**Design implications:**

* We’ll define a **single, shared dictionary** for product status:

  * **Active** – contract in force, usage & health fully relevant.
  * **Inactive** – purchased but not yet started / not activated.
  * **Will‑Churn** – post end‑date grace period; health still relevant to win‑back.
  * **Churned** – contract closed without renewal; health no longer actionable.
* This status will:

  * Appear explicitly in *Health by Products*.
  * Influence styling of the deeper lenses (e.g., greyed‑out charts for Churned).
  * Feed into notification and renewal strategies.

---

### 2.4 Navigation & explainability at Apex

Lastly, combining all of the above introduces **IA and explainability risk**:

* Users must be able to answer, quickly:

  * “Why is my Apex red?”
  * “Which subsidiaries and products are driving that?”
  * “Where do I click to see the evidence?”

Design‑wise, that means:

* Apex pages should behave more like **summary hubs** that point into the existing single‑account views, rather than attempting to show everything in one place.
* We will lean on **lists of hotspots** (subsidiaries/products in trouble) and **guided drill‑downs**.

---

## 3. How we propose to proceed (design next steps)

This section focuses on **what we do next**, not rehashing the past. The goal is to turn the conceptual model into concrete design work with minimal thrash.

### 3.1 Workstream A – Roll‑Up Rules & Apex Overview

**Objective:** Define and visualize how health and key KPIs roll up from subsidiary → Apex, and how we present this in an Apex Health Overview.

**Deliverables:**

1. **Roll‑up rules by metric category** (internal spec):

   * For each KPI we currently surface, document: roll‑up method (sum, weighted average, worst‑state, “no roll‑up – drill‑down only”).
   * Call out metrics that are *explicitly non‑roll‑up* (e.g., case lists, PS tables, pit‑stop timelines).

2. **Apex Account Health Overview wireframe:**

   * Shows Apex‑as‑account vs Apex roll‑up health side‑by‑side.
   * Includes a “Top problem subsidiaries” list with per‑product severity.
   * Provides clear drill‑downs into the existing single‑account lenses.

3. **IA diagram:**

   * Apex → Subsidiary → Product lens (Customer Estate / Deployment / Technical Health).

**Where we’ll need your input:**

* Confirmation of roll‑up behavior for MTTR and other time‑based metrics.
* Desired level of detail at Apex (e.g., is a simple “top 5 bad children” list enough, or do we need more structure?).

---

### 3.2 Workstream B – Subjective Health Model

**Objective:** Introduce a minimal, safe version of subjective health that supports field judgment without compromising trust in system data.

**Deliverables:**

1. **Subjective health spec:**

   * Exact fields where subjective values are allowed (starting with overall account health and Apex roll‑up health).
   * Required metadata (who, when, why, expiry).
   * Conflict resolution and display rules.

2. **UI patterns for dual health display:**

   * Badge layouts and tooltips for “System vs Field” states.
   * Example flows for adding/editing subjective health.

3. **Governance options:**

   * Option A: CSM‑only, no approval, short expiry.
   * Option B: CSM proposes, AE approves.
   * Option C: Pilot on a subset of accounts/products.

**Where we’ll need your input:**

* Which roles can set overrides.
* How long overrides should remain valid by default.
* Whether subjective health should feed into any reporting or is view‑only initially.

---

### 3.3 Workstream C – Product Status Dictionary & UX

**Objective:** Align on a shared lifecycle vocabulary and implement it consistently across the health experience.

**Deliverables:**

1. **Status dictionary v1:**

   * Active / Inactive / Will‑Churn / Churned with precise data conditions (contract start/end, grace window, etc.).

2. **Status → UX mapping:**

   * How each status affects:

     * Health by Products table (badges, greying, tooltips).
     * Deeper lenses (which charts stay active vs get dimmed).
     * Notifications and AI prompts (e.g., “Will‑Churn” drives renewal reminders).

3. **Edge‑case handling:**

   * Multi‑year deals with staggered lines.
   * Products moving from Churned back to Active (win‑back).

**Where we’ll need your input:**

* Confirmation of grace window semantics (e.g., T+30 vs T+60).
* The canonical contract data source and any nuances we should account for.

---

### 3.4 Workstream D – Apex IA & Explainability

**Objective:** Ensure that at Apex, the system tells a coherent story that can be used directly in QBRs and exec reviews.

**Deliverables:**

1. **Apex IA proposal:**

   * Navigation, breadcrumbs, and how users traverse Apex → child → product.

2. **Explainability patterns:**

   * How we answer “Why is this Apex red?” using a combination of:

     * Aggregated metrics
     * Highlighted subsidiaries/products
     * Links into the existing views

3. **QBR‑ready views:**

   * Identify which existing components (trends, timelines, estate views) can be safely reused in QBR decks and what additional summarization might be needed.

---

## 4. Decision checklist for you (what we need from Sumesh)

To keep things moving, here’s a concise list of decisions where your guidance will unlock progress:

1. **Roll‑ups**

   * Confirm approach for time‑based metrics (MTTR, deployment durations).
   * Confirm that detailed artifacts (case lists, PS tables, pit‑stops) remain non‑roll‑up and are handled via drill‑down.

2. **Subjective health**

   * Which fields we should enable in v1 (overall account, Apex roll‑up, others?).
   * Which roles can set or edit subjective health.
   * Default expiry window for overrides.

3. **Product lifecycle status**

   * Agreement on the four statuses (Active / Inactive / Will‑Churn / Churned).
   * Confirmation of grace period rules and contract data source.

4. **Apex IA expectations**

   * How “heavy” or “light” the Apex view should be (high‑level summary vs richer dashboard).
   * Priority personas for Apex (who we optimize for first: CSM, AE, leadership?).

---

## 5. Summary

We’re treating the work ahead as the evolution from a strong single‑account cockpit into a **coherent, multi‑layered health system** that:

* Represents both objective and subjective health,
* Handles the realities of Apex account structures,
* Clarifies product lifecycle status,
* And supports the real conversations teams have in QBRs and renewals.

The four workstreams above (Roll‑ups, Subjective Health, Product Status, Apex IA) are our proposed path to get there. Once we align on the outstanding decisions, we can move quickly into prototypes and validation with field stakeholders.

## ChatGPT (2025-12-03T18:42:36.899853+00:00)

{"content_type": "thoughts", "thoughts": [{"summary": "Aligning views and priorities", "content": "I'm aiming for clarity on the product lifecycle status, focusing on the four key stages (Active, Inactive, Will-Churn, Churned), as well as the grace period and contract data source. We'll also need to finalize Apex's general layout and prioritize personas like CSM, AE, or leadership within the interface. In summary, the goal is to evolve the system towards a multi-layered health view that integrates both objective and subjective health trends while supporting QBRs and renewals.", "chunks": [], "finished": true}], "source_analysis_msg_id": "c1555866-36b8-4bdf-a53e-191ad4e960d4"}

## ChatGPT (2025-12-03T18:41:51.333746+00:00)

{"content_type": "code", "language": "python3", "response_format_name": null, "text": "{}"}

## ChatGPT (2025-12-03T18:43:07.377920+00:00)

{"content_type": "thoughts", "thoughts": [{"summary": "Next steps: governance and status dictionary", "content": "We’ll need input on which roles can set subjective health overrides, how long those overrides should last, and if they should influence reporting from the get-go. On the product status, we’re establishing a shared vocabulary (Active/Inactivated/Will‑Churn/Churned) and defining how they will impact the user experience.", "chunks": [], "finished": true}], "source_analysis_msg_id": "a258b01b-a43c-47fe-b8da-c60984e6ee2c"}

## ChatGPT (2025-12-03T18:43:02.524243+00:00)

{"content_type": "code", "language": "unknown", "response_format_name": null, "text": "{\"actions\":[{\"action\":\"click\",\"x\":243,\"y\":216,\"button\":1},{\"action\":\"keypress\",\"keys\":[\"ctrl\",\"a\"]},{\"action\":\"type\",\"text\":\"# Account Health \\u2013 Scope Confirmation & Next Steps  \\n\\nThanks \\u2014 now that we have the latest designs, the meeting transcript, and alignment on the core vision, this document summarizes how we (design) are understanding the scope **and** how we propose to move forward.  \\n\\nThis is written to:  \\n\\n- Show that we clearly understand the problem space and future direction.  \\n- Call out where we see complexity or risk (roll\\u2011ups, subjective health, lifecycle status, IA).  \\n- Propose concrete next steps so we can move from concept to executable design work.  \\n\\nIt deliberately **does not restate** all of the existing UI or metrics; everyone here already knows the current system well. Instead, it focuses on the *delta* we need to design for.  \\n\\n---  \\n\\n## 1. What we heard and how we\\u2019re framing the problem  \\n\\nFrom the recent conversations, we\\u2019re treating \\u201cAccount Health\\u201d as evolving from a **single\\u2011account cockpit** into a **multi\\u2011layered health system** that must support:  \\n\\n1. **Apex accounts** with subsidiaries, where health exists at:  \\n\\n   - Individual account level (\\\"Alphabet as a customer\\\").  \\n   - Apex roll\\u2011up level (\\\"Alphabet as a parent of Google, YouTube, Boston Dynamics, etc.\\\").  \\n\\n2. **Two parallel views of health**:  \\n\\n   - **Objective health** \\u2013 system\\u2011calculated scores derived from existing KPIs (deployment, technical, adoption, support).  \\n   - **Subjective health** \\u2013 field / account\\u2011team judgment that layers additional context on top of system data.  \\n\\n3. **Explainability and root cause clarity**, without forcing users to hunt through multiple tabs to understand why a product or account is red.  \\n\\n4. **Clear product lifecycle status** (Active, Inactive, Will\\u2011Churn, Churned) that shapes how health is interpreted and how QBR / renewal conversations happen.  \\n\\nOur goal as design is to make this system **legible, navigable, and trustworthy** for the people who use it in high\\u2011stakes conversations (CSMs, AEs, execs), while keeping the implementation viable for data and engineering.  \\n\\n---  \\n\\n## 2. Where we see complexity / potential issues  \\n\\nBelow are the key areas where we see design and system complexity. These are also the areas where further alignment and documentation will reduce risk and rework later.  \\n\\n### 2.1 Roll\\u2011ups (Apex \\u2194 subsidiary \\u2194 product)  \\n\\n**What\\u2019s straightforward:**  \\n\\n- We can roll up *counts* and *rates* (e.g., case counts, MTTR, adoption %, license volumes) as long as we agree on the aggregation rules.  \\n- We can roll up health states using a simple hierarchy (Critical > At\\u2011Risk > Healthy).  \\n\\n**Where we see potential issues:**  \\n\\n1. **\\\"Two truths\\\" at the Apex level.**  \\n\\n   - Example: Alphabet as a standalone account is Healthy; Alphabet as a roll\\u2011up is Critical because Boston Dynamics is red.  \\n   - We need a clear pattern to show **both** without confusing users.  \\n\\n2. **Not everything can be meaningfully rolled up.**  \\n\\n   - Detailed artifacts like case lists, pit\\u2011stop timelines, PS project tables, and configuration details lose meaning when merged.  \\n   - For these, roll\\u2011up should be: **aggregated signal + drill\\u2011down**, not a single mega\\u2011timeline or mega\\u2011table.  \\n\\n3. **Health semantics across different products.**  \\n\\n   - Health drivers for Prisma Access vs CDSS vs PA\\u2011Series are structurally different.  \\n   - We should ensure the roll\\u2011up doesn\\u2019t imply false equivalence (e.g., a single \\u201cCritical\\u201d that hides whether it\\u2019s deployment\\u2011driven or technical\\u2011driven).  \\n\\n4. **IA and mental model at Apex.**  \\n\\n   - Today, all screens assume \\u201cone account.\\u201d  \\n   - At Apex, users need to understand: *Which subsidiaries are pulling us down? Which products at which subsidiaries? How do I drill into that quickly?*  \\n\\n**Design implications:**  \\n\\n- Apex view must explicitly distinguish:  \\n\\n  - **Apex\\u2011as\\u2011account health** (direct purchases/install base).  \\n  - **Apex roll\\u2011up health** (aggregated subsidiary impact).  \\n- We\\u2019ll prefer a **summary + hotspot list** pattern: e.g., \\u201cTop 3 subsidiaries dragging health down,\\u201d each with direct links into the existing single\\u2011account lenses.  \\n- For metrics that don\\u2019t roll up well, we will **not** force aggregation and will instead provide guided paths to the right child views.  \\n\\n---  \\n\\n### 2.2 Subjective health (human judgment on top of system scores)  \\n\\nWe haven\\u2019t yet established subjective overrides as a full workflow, but the need is clear:  \\n\\n- Field teams want to express, \\u201cThe system shows Critical, but we\\u2019ve mitigated the underlying issue and are confident,\\u201d or the opposite.  \\n\\n**Key complexities we see:**  \\n\\n1. **Scope of overrides.**  \\n\\n   - We believe overrides should apply only to **health states**, not raw metrics.  \\n   - Candidate fields:  \\n\\n     - Overall account health  \\n     - Technical health  \\n     - Deployment & adoption health  \\n     - Apex roll\\u2011up health (for leadership\\u2011level judgment)  \\n     - (Optional) per\\u2011product health where necessary  \\n\\n2. **Governance and roles.**  \\n\\n   - Who is allowed to set subjective health? CSM, AE, renewal rep, SE?  \\n   - Does it require approval or is it a free\\u2011form note?  \\n\\n3. **Lifetime and freshness.**  \\n\\n   - An override from six months ago is dangerous if it outlives the underlying data.  \\n   - We\\u2019ll need rules like: *expires after X days* or *must be renewed when system health changes state*.  \\n\\n4. **Conflict representation.**  \\n\\n   - System says Critical, field says Healthy.  \\n   - We need a clear, non\\u2011ambiguous visual pattern that shows **both** and invites the user to understand why.  \\n\\n**Design implications:**  \\n\\n- We should treat subjective health as a **layer of annotation** with metadata (who, when, why), not a replacement field.  \\n- The UI will show dual badges, e.g., \\u201cSystem: Critical / Field: At\\u2011Risk,\\u201d with a quick way to see the justification.  \\n- In the first iteration, we\\u2019d recommend keeping overrides limited to **overall account and Apex roll\\u2011up** to reduce complexity.  \\n\\n---  \\n\\n### 2.3 Product & lifecycle status (Active / Inactive / Will\\u2011Churn / Churned)  \\n\\nRight now, the designs surface a lot of lifecycle signals (support active/inactive, license terms, etc.), but the **state vocabulary isn\\u2019t unified**. That creates risk of:  \\n\\n- Misaligned mental models between CS, Renewals, and Product.  \\n- Health scores on products that are effectively \\u201cdead\\u201d or \\u201cnot yet started.\\u201d  \\n\\n**Where we see issues:**  \\n\\n1. **Fragmented labels.**  \\n\\n   - \\u201cInactive support,\\u201d \\u201cnever had support,\\u201d expired licenses, etc., all communicate lifecycle in different ways.  \\n\\n2. **Health on products that shouldn\\u2019t be evaluated.**  \\n\\n   - A churned product shouldn\\u2019t show \\u201cCritical\\u201d health in the same way as an active one; that confuses QBR messaging.  \\n\\n3. **Renewal workflows.**  \\n\\n   - The \\u201cWill\\u2011Churn\\u201d window (contract ended, tenant still active, renewal in play) is key for CS and Renewals, but today it\\u2019s not clearly visualized.  \\n\\n**Design implications:**  \\n\\n- We\\u2019ll define a **single, shared dictionary** for product status:  \\n\\n  - **Active** \\u2013 contract in force, usage & health fully relevant.  \\n  - **Inactive** \\u2013 purchased but not yet started / not activated.  \\n  - **Will\\u2011Churn** \\u2013 post end\\u2011date grace period; health still relevant to win\\u2011back.  \\n  - **Churned** \\u2013 contract closed without renewal; health no longer actionable.  \\n- This status will:  \\n\\n  - Appear explicitly in *Health by Products*.  \\n  - Influence styling of the deeper lenses (e.g., greyed\\u2011out charts for Churned).  \\n  - Feed into notification and renewal strategies.  \\n\\n---  \\n\\n### 2.4 Navigation & explainability at Apex  \\n\\nLastly, combining all of the above introduces **IA and explainability risk**:  \\n\\n- Users must be able to answer, quickly:  \\n\\n  - \\u201cWhy is my Apex red?\\u201d  \\n  - \\u201cWhich subsidiaries and products are driving that?\\u201d  \\n  - \\u201cWhere do I click to see the evidence?\\u201d  \\n\\nDesign\\u2011wise, that means:  \\n\\n- Apex pages should behave more like **summary hubs** that point into the existing single\\u2011account views, rather than attempting to show everything in one place.  \\n- We will lean on **lists of hotspots** (subsidiaries/products in trouble) and **guided drill\\u2011downs**.  \\n\\n---  \\n\\n## 3. How we propose to proceed (design next steps)  \\n\\nThis section focuses on **what we do next**, not rehashing the past. The goal is to turn the conceptual model into concrete design work with minimal thrash.  \\n\\n### 3.1 Workstream A \\u2013 Roll\\u2011Up Rules & Apex Overview  \\n\\n**Objective:** Define and visualize how health and key KPIs roll up from subsidiary \\u2192 Apex, and how we present this in an Apex Health Overview.  \\n\\n**Deliverables:**  \\n\\n1. **Roll\\u2011up rules by metric category** (internal spec):  \\n\\n   - For each KPI we currently surface, document: roll\\u2011up method (sum, weighted average, worst\\u2011state, \\u201cno roll\\u2011up \\u2013 drill\\u2011down only\\u201d).  \\n   - Call out metrics that are *explicitly non\\u2011roll\\u2011up* (e.g., case lists, PS tables, pit\\u2011stop timelines).  \\n\\n2. **Apex Account Health Overview wireframe:**  \\n\\n   - Shows Apex\\u2011as\\u2011account vs Apex roll\\u2011up health side\\u2011by\\u2011side.  \\n   - Includes a \\u201cTop problem subsidiaries\\u201d list with per\\u2011product severity.  \\n   - Provides clear drill\\u2011downs into the existing single\\u2011account lenses.  \\n\\n3. **IA diagram:**  \\n\\n   - Apex \\u2192 Subsidiary \\u2192 Product lens (Customer Estate / Deployment / Technical Health).  \\n\\n**Where we\\u2019ll need your input:**  \\n\\n- Confirmation of roll\\u2011up behavior for MTTR and other time\\u2011based metrics.  \\n- Desired level of detail at Apex (e.g., is a simple \\u201ctop 5 bad children\\u201d list enough, or do we need more structure?).  \\n\\n---  \\n\\n### 3.2 Workstream B \\u2013 Subjective Health Model  \\n\\n**Objective:** Introduce a minimal, safe version of subjective health that supports field judgment without compromising trust in system data.  \\n\\n**Deliverables:**  \\n\\n1. **Subjective health spec:**  \\n\\n   - Exact fields where subjective values are allowed (starting with overall account health and Apex roll\\u2011up health).  \\n   - Required metadata (who, when, why, expiry).  \\n   - Conflict resolution and display rules.  \\n\\n2. **UI patterns for dual health display:**  \\n\\n   - Badge layouts and tooltips for \\u201cSystem vs Field\\u201d states.  \\n   - Example flows for adding/editing subjective health.  \\n\\n3. **Governance options:**  \\n\\n   - Option A: CSM\\u2011only, no approval, short expiry.  \\n   - Option B: CSM proposes, AE approves.  \\n   - Option C: Pilot on a subset of accounts/products.  \\n\\n**Where we\\u2019ll need your input:**  \\n\\n- Which roles can set overrides.  \\n- How long overrides should remain valid by default.  \\n- Whether subjective health should feed into any reporting or is view\\u2011only initially.  \\n\\n---  \\n\\n### 3.3 Workstream C \\u2013 Product Status Dictionary & UX  \\n\\n**Objective:** Align on a shared lifecycle vocabulary and implement it consistently across the health experience.  \\n\\n**Deliverables:**  \\n\\n1. **Status dictionary v1:**  \\n\\n   - Active / Inactive / Will\\u2011Churn / Churned with precise data conditions (contract start/end, grace window, etc.).  \\n\\n2. **Status \\u2192 UX mapping:**  \\n\\n   - How each status affects:  \\n\\n     - Health by Products table (badges, greying, tooltips).  \\n     - Deeper lenses (which charts stay active vs get dimmed).  \\n     - Notifications and AI prompts (e.g., \\u201cWill\\u2011Churn\\u201d drives renewal reminders).  \\n\\n3. **Edge\\u2011case handling:**  \\n\\n   - Multi\\u2011year deals with staggered lines.  \\n   - Products moving from Churned back to Active (win\\u2011back).  \\n\\n**Where we\\u2019ll need your input:**  \\n\\n- Confirmation of grace window semantics (e.g., T+30 vs T+60).  \\n- The canonical contract data source and any nuances we should account for.  \\n\\n---  \\n\\n### 3.4 Workstream D \\u2013 Apex IA & Explainability  \\n\\n**Objective:** Ensure that at Apex, the system tells a coherent story that can be used directly in QBRs and exec reviews.  \\n\\n**Deliverables:**  \\n\\n1. **Apex IA proposal:**  \\n\\n   - Navigation, breadcrumbs, and how users traverse Apex \\u2192 child \\u2192 product.  \\n\\n2. **Explainability patterns:**  \\n\\n   - How we answer \\u201cWhy is this Apex red?\\u201d using a combination of:  \\n\\n     - Aggregated metrics  \\n     - Highlighted subsidiaries/products  \\n     - Links into the existing views  \\n\\n3. **QBR\\u2011ready views:**  \\n\\n   - Identify which existing components (trends, timelines, estate views) can be safely reused in QBR decks and what additional summarization might be needed.  \\n\\n---  \\n\\n## 4. Decision checklist for you (what we need from Sumesh)  \\n\\nTo keep things moving, here\\u2019s a concise list of decisions where your guidance will unlock progress:  \\n\\n1. **Roll\\u2011ups**  \\n\\n   - Confirm approach for time\\u2011based metrics (MTTR, deployment durations).  \\n   - Confirm that detailed artifacts (case lists, PS tables, pit\\u2011stops) remain non\\u2011roll\\u2011up and are handled via drill\\u2011down.  \\n\\n2. **Subjective health**  \\n\\n   - Which fields we should enable in v1 (overall account, Apex roll\\u2011up, others?).  \\n   - Which roles can set or edit subjective health.  \\n   - Default expiry window for overrides.  \\n\\n3. **Product lifecycle status**  \\n\\n   - Agreement on the four statuses (Active / Inactive / Will\\u2011Churn / Churned).  \\n   - Confirmation of grace period rules and contract data source.  \\n\\n4. **Apex IA expectations**  \\n\\n   - How \\u201cheavy\\u201d or \\u201clight\\u201d the Apex view should be (high\\u2011level summary vs richer dashboard).  \\n   - Priority personas for Apex (who we optimize for first: CSM, AE, leadership?).  \\n\\n---  \\n\\n## 5. Summary  \\n\\nWe\\u2019re treating the work ahead as the evolution from a strong single\\u2011account cockpit into a **coherent, multi\\u2011layered health system** that:  \\n\\n- Represents both objective and subjective health,  \\n- Handles the realities of Apex account structures,  \\n- Clarifies product lifecycle status,  \\n- And supports the real conversations teams have in QBRs and renewals.  \\n\\nThe four workstreams above (Roll\\u2011ups, Subjective Health, Product Status, Apex IA) are our proposed path to get there. Once we align on the outstanding decisions, we can move quickly into prototypes and validation with field stakeholders.  \"}]}"}

## ChatGPT (2025-12-03T18:43:09.258140+00:00)

{"content_type": "code", "language": "unknown", "response_format_name": null, "text": "{}"}

## ChatGPT (2025-12-03T18:43:13.426833+00:00)

{"content_type": "code", "language": "unknown", "response_format_name": null, "text": "{\"actions\":[{\"action\":\"dom_scroll\",\"scroll_x\":0,\"scroll_y\":656,\"node_id\":\"3844ec02\"}]}"}

## ChatGPT (2025-12-03T18:43:23.607112+00:00)

{"content_type": "reasoning_recap", "content": "Worked for 2 minutes"}

## ChatGPT (2025-12-03T18:43:18.414783+00:00)

I've added the provided content to your document using appropriate markdown-style headings and bullet lists. The document now reflects the full scope confirmation, complexity analysis, proposed workstreams, decision checklist, and summary sections, all formatted clearly and consistently. You can review the updated document to ensure everything looks good and matches your expectations【122999379062213†screenshot】.

